Structure

Physi-Chem Properties

Molecular Weight:  250.16
Volume:  269.345
LogP:  1.815
LogD:  1.691
LogS:  -2.95
# Rotatable Bonds:  2
TPSA:  57.53
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.789
Synthetic Accessibility Score:  4.327
Fsp3:  0.667
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.664
MDCK Permeability:  2.131986548192799e-05
Pgp-inhibitor:  0.059
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.763
Plasma Protein Binding (PPB):  86.63166046142578%
Volume Distribution (VD):  0.919
Pgp-substrate:  16.26361656188965%

ADMET: Metabolism

CYP1A2-inhibitor:  0.028
CYP1A2-substrate:  0.551
CYP2C19-inhibitor:  0.043
CYP2C19-substrate:  0.859
CYP2C9-inhibitor:  0.023
CYP2C9-substrate:  0.25
CYP2D6-inhibitor:  0.013
CYP2D6-substrate:  0.152
CYP3A4-inhibitor:  0.046
CYP3A4-substrate:  0.427

ADMET: Excretion

Clearance (CL):  4.139
Half-life (T1/2):  0.764

ADMET: Toxicity

hERG Blockers:  0.035
Human Hepatotoxicity (H-HT):  0.319
Drug-inuced Liver Injury (DILI):  0.041
AMES Toxicity:  0.074
Rat Oral Acute Toxicity:  0.062
Maximum Recommended Daily Dose:  0.143
Skin Sensitization:  0.161
Carcinogencity:  0.405
Eye Corrosion:  0.006
Eye Irritation:  0.084
Respiratory Toxicity:  0.52

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470298

Natural Product ID:  NPC470298
Common Name*:   Oxyphyllanene F
IUPAC Name:   (4aR)-7-(1,2-dihydroxypropan-2-yl)-1,4a-dimethyl-3,4,5,6-tetrahydronaphthalen-2-one
Synonyms:   Oxyphyllanene F
Standard InCHIKey:  FPOORCYPPCUIJT-GICMACPYSA-N
Standard InCHI:  InChI=1S/C15H22O3/c1-10-12-8-11(15(3,18)9-16)4-6-14(12,2)7-5-13(10)17/h8,16,18H,4-7,9H2,1-3H3/t14-,15?/m1/s1
SMILES:  OCC(C1=CC2=C(C)C(=O)CC[C@]2(CC1)C)(O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1949799
PubChem CID:   57393408
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids
          • [CHEMONTID:0000101] Eudesmane, isoeudesmane or cycloeudesmane sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/0031-9422(81)85171-0]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[11514174]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota fruit Hainan Island, China 1998 PMID[12398545]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[22277277]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[23583435]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[25757283]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO22715 Alpinia oxyphylla Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 13.95 ug.mL-1 PMID[506141]
NPT34 Cell Line BV-2 Mus musculus MNTD = 0.1 uM PMID[506142]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470298 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8554 High Similarity NPC15807
0.8537 High Similarity NPC251475
0.8537 High Similarity NPC169941
0.85 High Similarity NPC281138
0.8354 Intermediate Similarity NPC263582
0.8354 Intermediate Similarity NPC470525
0.8333 Intermediate Similarity NPC470299
0.8312 Intermediate Similarity NPC84790
0.8293 Intermediate Similarity NPC121984
0.8272 Intermediate Similarity NPC308038
0.8235 Intermediate Similarity NPC472974
0.8228 Intermediate Similarity NPC114236
0.8205 Intermediate Similarity NPC247586
0.8182 Intermediate Similarity NPC116726
0.8171 Intermediate Similarity NPC172013
0.8148 Intermediate Similarity NPC62336
0.8148 Intermediate Similarity NPC475994
0.814 Intermediate Similarity NPC287079
0.8132 Intermediate Similarity NPC161147
0.8095 Intermediate Similarity NPC66764
0.8095 Intermediate Similarity NPC110150
0.8072 Intermediate Similarity NPC6663
0.8068 Intermediate Similarity NPC473099
0.8049 Intermediate Similarity NPC19900
0.8025 Intermediate Similarity NPC74995
0.8025 Intermediate Similarity NPC266193
0.8025 Intermediate Similarity NPC197659
0.8025 Intermediate Similarity NPC257666
0.8 Intermediate Similarity NPC40687
0.8 Intermediate Similarity NPC196227
0.8 Intermediate Similarity NPC476412
0.7976 Intermediate Similarity NPC158411
0.7976 Intermediate Similarity NPC93590
0.7976 Intermediate Similarity NPC38796
0.7955 Intermediate Similarity NPC36668
0.7955 Intermediate Similarity NPC473100
0.7955 Intermediate Similarity NPC118011
0.7952 Intermediate Similarity NPC271104
0.7952 Intermediate Similarity NPC2482
0.7935 Intermediate Similarity NPC474785
0.7935 Intermediate Similarity NPC135685
0.7935 Intermediate Similarity NPC474938
0.7935 Intermediate Similarity NPC470522
0.7927 Intermediate Similarity NPC275494
0.7927 Intermediate Similarity NPC471409
0.7927 Intermediate Similarity NPC178852
0.7907 Intermediate Similarity NPC179006
0.7907 Intermediate Similarity NPC474853
0.7907 Intermediate Similarity NPC187529
0.7901 Intermediate Similarity NPC472305
0.7895 Intermediate Similarity NPC473624
0.7889 Intermediate Similarity NPC109305
0.7889 Intermediate Similarity NPC474736
0.7875 Intermediate Similarity NPC215050
0.7865 Intermediate Similarity NPC69622
0.7841 Intermediate Similarity NPC72397
0.7831 Intermediate Similarity NPC152061
0.7826 Intermediate Similarity NPC117133
0.7821 Intermediate Similarity NPC473893
0.7816 Intermediate Similarity NPC473168
0.7816 Intermediate Similarity NPC89077
0.7816 Intermediate Similarity NPC194417
0.7805 Intermediate Similarity NPC34110
0.7805 Intermediate Similarity NPC325946
0.7805 Intermediate Similarity NPC86917
0.7802 Intermediate Similarity NPC474882
0.7802 Intermediate Similarity NPC472977
0.7802 Intermediate Similarity NPC472976
0.7802 Intermediate Similarity NPC473162
0.7778 Intermediate Similarity NPC19114
0.7778 Intermediate Similarity NPC475441
0.775 Intermediate Similarity NPC186042
0.7738 Intermediate Similarity NPC148685
0.7738 Intermediate Similarity NPC472301
0.7738 Intermediate Similarity NPC157895
0.7738 Intermediate Similarity NPC104120
0.7738 Intermediate Similarity NPC45495
0.7727 Intermediate Similarity NPC136548
0.7711 Intermediate Similarity NPC297996
0.7711 Intermediate Similarity NPC189485
0.7701 Intermediate Similarity NPC476426
0.7701 Intermediate Similarity NPC474083
0.7692 Intermediate Similarity NPC472942
0.7683 Intermediate Similarity NPC250621
0.7683 Intermediate Similarity NPC151622
0.7683 Intermediate Similarity NPC7629
0.7674 Intermediate Similarity NPC49019
0.7674 Intermediate Similarity NPC64600
0.7667 Intermediate Similarity NPC134321
0.7667 Intermediate Similarity NPC48010
0.766 Intermediate Similarity NPC166745
0.766 Intermediate Similarity NPC235464
0.766 Intermediate Similarity NPC471717
0.7654 Intermediate Similarity NPC213223
0.7647 Intermediate Similarity NPC226068
0.7647 Intermediate Similarity NPC116797
0.7647 Intermediate Similarity NPC225515
0.764 Intermediate Similarity NPC44181
0.7619 Intermediate Similarity NPC474113
0.7619 Intermediate Similarity NPC7232
0.7614 Intermediate Similarity NPC179591
0.7614 Intermediate Similarity NPC239685
0.7614 Intermediate Similarity NPC470955
0.7614 Intermediate Similarity NPC472985
0.7614 Intermediate Similarity NPC472986
0.7609 Intermediate Similarity NPC474690
0.7609 Intermediate Similarity NPC299100
0.7609 Intermediate Similarity NPC473172
0.7604 Intermediate Similarity NPC473424
0.759 Intermediate Similarity NPC203403
0.759 Intermediate Similarity NPC97377
0.759 Intermediate Similarity NPC471061
0.7586 Intermediate Similarity NPC472326
0.7586 Intermediate Similarity NPC473246
0.7582 Intermediate Similarity NPC475806
0.7564 Intermediate Similarity NPC278895
0.7558 Intermediate Similarity NPC212083
0.7558 Intermediate Similarity NPC103486
0.7556 Intermediate Similarity NPC472973
0.7556 Intermediate Similarity NPC472688
0.7556 Intermediate Similarity NPC309603
0.7556 Intermediate Similarity NPC472983
0.7556 Intermediate Similarity NPC214387
0.7556 Intermediate Similarity NPC472676
0.7556 Intermediate Similarity NPC123912
0.7556 Intermediate Similarity NPC473999
0.7556 Intermediate Similarity NPC474918
0.7553 Intermediate Similarity NPC208094
0.7531 Intermediate Similarity NPC29542
0.7531 Intermediate Similarity NPC201562
0.7531 Intermediate Similarity NPC323437
0.7529 Intermediate Similarity NPC74086
0.7529 Intermediate Similarity NPC306095
0.7529 Intermediate Similarity NPC470946
0.7529 Intermediate Similarity NPC470945
0.7529 Intermediate Similarity NPC108955
0.7529 Intermediate Similarity NPC471514
0.7529 Intermediate Similarity NPC470947
0.7528 Intermediate Similarity NPC470523
0.7528 Intermediate Similarity NPC220930
0.7528 Intermediate Similarity NPC272039
0.7528 Intermediate Similarity NPC181327
0.7528 Intermediate Similarity NPC312561
0.7527 Intermediate Similarity NPC180950
0.7527 Intermediate Similarity NPC472932
0.7527 Intermediate Similarity NPC259286
0.7526 Intermediate Similarity NPC475050
0.75 Intermediate Similarity NPC134826
0.75 Intermediate Similarity NPC231739
0.75 Intermediate Similarity NPC250575
0.75 Intermediate Similarity NPC74410
0.75 Intermediate Similarity NPC32037
0.75 Intermediate Similarity NPC472930
0.75 Intermediate Similarity NPC70685
0.75 Intermediate Similarity NPC478122
0.75 Intermediate Similarity NPC471224
0.75 Intermediate Similarity NPC274724
0.75 Intermediate Similarity NPC169095
0.75 Intermediate Similarity NPC173321
0.75 Intermediate Similarity NPC469948
0.75 Intermediate Similarity NPC79573
0.75 Intermediate Similarity NPC69454
0.7473 Intermediate Similarity NPC129913
0.7473 Intermediate Similarity NPC477149
0.7473 Intermediate Similarity NPC128672
0.7473 Intermediate Similarity NPC477147
0.7471 Intermediate Similarity NPC105173
0.7471 Intermediate Similarity NPC477785
0.7471 Intermediate Similarity NPC477784
0.7471 Intermediate Similarity NPC477786
0.7471 Intermediate Similarity NPC297398
0.7447 Intermediate Similarity NPC471463
0.7447 Intermediate Similarity NPC473164
0.7447 Intermediate Similarity NPC249954
0.7444 Intermediate Similarity NPC470524
0.7444 Intermediate Similarity NPC471793
0.7444 Intermediate Similarity NPC471722
0.7444 Intermediate Similarity NPC53454
0.7444 Intermediate Similarity NPC471791
0.7444 Intermediate Similarity NPC474854
0.7442 Intermediate Similarity NPC275766
0.7442 Intermediate Similarity NPC136150
0.7442 Intermediate Similarity NPC4166
0.7442 Intermediate Similarity NPC55869
0.7439 Intermediate Similarity NPC301065
0.7419 Intermediate Similarity NPC181393
0.7419 Intermediate Similarity NPC8993
0.7419 Intermediate Similarity NPC78159
0.7419 Intermediate Similarity NPC217624
0.7416 Intermediate Similarity NPC474733
0.7416 Intermediate Similarity NPC82979
0.7416 Intermediate Similarity NPC475022
0.7416 Intermediate Similarity NPC474778
0.7416 Intermediate Similarity NPC145879
0.7416 Intermediate Similarity NPC474732
0.7416 Intermediate Similarity NPC118648
0.7416 Intermediate Similarity NPC94666
0.7416 Intermediate Similarity NPC473226
0.7416 Intermediate Similarity NPC31564
0.7416 Intermediate Similarity NPC222613

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470298 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7701 Intermediate Similarity NPD1696 Phase 3
0.7614 Intermediate Similarity NPD5279 Phase 3
0.7529 Intermediate Similarity NPD8259 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD4519 Discontinued
0.7416 Intermediate Similarity NPD4623 Approved
0.7416 Intermediate Similarity NPD5280 Approved
0.7416 Intermediate Similarity NPD4694 Approved
0.7386 Intermediate Similarity NPD3133 Approved
0.7386 Intermediate Similarity NPD3666 Approved
0.7386 Intermediate Similarity NPD3665 Phase 1
0.7356 Intermediate Similarity NPD3667 Approved
0.7253 Intermediate Similarity NPD4518 Approved
0.7222 Intermediate Similarity NPD3618 Phase 1
0.7215 Intermediate Similarity NPD7331 Phase 2
0.7191 Intermediate Similarity NPD4786 Approved
0.7174 Intermediate Similarity NPD4753 Phase 2
0.7159 Intermediate Similarity NPD4221 Approved
0.7159 Intermediate Similarity NPD4223 Phase 3
0.7126 Intermediate Similarity NPD4695 Discontinued
0.7033 Intermediate Similarity NPD5690 Phase 2
0.7021 Intermediate Similarity NPD5281 Approved
0.7021 Intermediate Similarity NPD5284 Approved
0.7 Intermediate Similarity NPD4197 Approved
0.6989 Remote Similarity NPD5328 Approved
0.6989 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6947 Remote Similarity NPD4202 Approved
0.6947 Remote Similarity NPD5779 Approved
0.6947 Remote Similarity NPD5778 Approved
0.6941 Remote Similarity NPD8264 Approved
0.6923 Remote Similarity NPD5329 Approved
0.6915 Remote Similarity NPD4096 Approved
0.6875 Remote Similarity NPD7341 Phase 2
0.686 Remote Similarity NPD6933 Approved
0.6848 Remote Similarity NPD5205 Approved
0.6848 Remote Similarity NPD4689 Approved
0.6848 Remote Similarity NPD4690 Approved
0.6848 Remote Similarity NPD4138 Approved
0.6848 Remote Similarity NPD4688 Approved
0.6848 Remote Similarity NPD4693 Phase 3
0.6842 Remote Similarity NPD6411 Approved
0.6842 Remote Similarity NPD6079 Approved
0.6842 Remote Similarity NPD7515 Phase 2
0.6804 Remote Similarity NPD5695 Phase 3
0.6804 Remote Similarity NPD5210 Approved
0.6804 Remote Similarity NPD4629 Approved
0.6782 Remote Similarity NPD4756 Discovery
0.6771 Remote Similarity NPD5133 Approved
0.6744 Remote Similarity NPD8039 Approved
0.6733 Remote Similarity NPD5211 Phase 2
0.6705 Remote Similarity NPD3617 Approved
0.6667 Remote Similarity NPD6083 Phase 2
0.6667 Remote Similarity NPD6084 Phase 2
0.6667 Remote Similarity NPD4755 Approved
0.6667 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6632 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6632 Remote Similarity NPD6101 Approved
0.663 Remote Similarity NPD3668 Phase 3
0.6628 Remote Similarity NPD4687 Approved
0.6628 Remote Similarity NPD6924 Approved
0.6628 Remote Similarity NPD6926 Approved
0.6628 Remote Similarity NPD5733 Approved
0.6602 Remote Similarity NPD5141 Approved
0.6588 Remote Similarity NPD5276 Approved
0.6579 Remote Similarity NPD342 Phase 1
0.6566 Remote Similarity NPD5222 Approved
0.6566 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6566 Remote Similarity NPD4697 Phase 3
0.6566 Remote Similarity NPD5221 Approved
0.6562 Remote Similarity NPD5207 Approved
0.6562 Remote Similarity NPD5692 Phase 3
0.6559 Remote Similarity NPD1694 Approved
0.6556 Remote Similarity NPD6931 Approved
0.6556 Remote Similarity NPD6930 Phase 2
0.6545 Remote Similarity NPD7115 Discovery
0.6535 Remote Similarity NPD5286 Approved
0.6535 Remote Similarity NPD6404 Discontinued
0.6535 Remote Similarity NPD4696 Approved
0.6535 Remote Similarity NPD5285 Approved
0.6535 Remote Similarity NPD4700 Approved
0.6531 Remote Similarity NPD7748 Approved
0.6522 Remote Similarity NPD4788 Approved
0.6517 Remote Similarity NPD7322 Clinical (unspecified phase)
0.6517 Remote Similarity NPD5784 Clinical (unspecified phase)
0.65 Remote Similarity NPD4194 Approved
0.65 Remote Similarity NPD4192 Approved
0.65 Remote Similarity NPD4193 Approved
0.65 Remote Similarity NPD368 Approved
0.65 Remote Similarity NPD4191 Approved
0.65 Remote Similarity NPD5173 Approved
0.6495 Remote Similarity NPD6050 Approved
0.6495 Remote Similarity NPD5694 Approved
0.6494 Remote Similarity NPD4219 Approved
0.6489 Remote Similarity NPD7521 Approved
0.6489 Remote Similarity NPD7334 Approved
0.6489 Remote Similarity NPD5330 Approved
0.6489 Remote Similarity NPD6409 Approved
0.6489 Remote Similarity NPD7146 Approved
0.6489 Remote Similarity NPD6684 Approved
0.6484 Remote Similarity NPD4139 Approved
0.6484 Remote Similarity NPD4692 Approved
0.6471 Remote Similarity NPD5223 Approved
0.6444 Remote Similarity NPD4195 Approved
0.6444 Remote Similarity NPD6929 Approved
0.6437 Remote Similarity NPD4058 Approved
0.6436 Remote Similarity NPD4225 Approved
0.6436 Remote Similarity NPD5696 Approved
0.6429 Remote Similarity NPD6399 Phase 3
0.6421 Remote Similarity NPD7524 Approved
0.642 Remote Similarity NPD2664 Clinical (unspecified phase)
0.6413 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6408 Remote Similarity NPD5224 Approved
0.6408 Remote Similarity NPD4633 Approved
0.6408 Remote Similarity NPD5225 Approved
0.6408 Remote Similarity NPD5226 Approved
0.6392 Remote Similarity NPD5785 Approved
0.6392 Remote Similarity NPD46 Approved
0.6392 Remote Similarity NPD6698 Approved
0.6386 Remote Similarity NPD3704 Approved
0.6383 Remote Similarity NPD5363 Approved
0.6374 Remote Similarity NPD7332 Phase 2
0.6374 Remote Similarity NPD7514 Phase 3
0.6354 Remote Similarity NPD5737 Approved
0.6354 Remote Similarity NPD6672 Approved
0.6354 Remote Similarity NPD6903 Approved
0.6354 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6353 Remote Similarity NPD4137 Phase 3
0.6346 Remote Similarity NPD5175 Approved
0.6346 Remote Similarity NPD5174 Approved
0.6346 Remote Similarity NPD4754 Approved
0.6344 Remote Similarity NPD6695 Phase 3
0.6337 Remote Similarity NPD7902 Approved
0.6327 Remote Similarity NPD7983 Approved
0.6321 Remote Similarity NPD6412 Phase 2
0.6296 Remote Similarity NPD4634 Approved
0.6292 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6279 Remote Similarity NPD4691 Approved
0.6279 Remote Similarity NPD4747 Approved
0.6277 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6277 Remote Similarity NPD7338 Clinical (unspecified phase)
0.625 Remote Similarity NPD4751 Clinical (unspecified phase)
0.625 Remote Similarity NPD3573 Approved
0.6239 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6237 Remote Similarity NPD4270 Approved
0.6237 Remote Similarity NPD4269 Approved
0.6226 Remote Similarity NPD6675 Approved
0.6226 Remote Similarity NPD5739 Approved
0.6226 Remote Similarity NPD6402 Approved
0.6226 Remote Similarity NPD7128 Approved
0.6226 Remote Similarity NPD4768 Approved
0.6226 Remote Similarity NPD4767 Approved
0.6222 Remote Similarity NPD6925 Approved
0.6222 Remote Similarity NPD5776 Phase 2
0.6214 Remote Similarity NPD7639 Approved
0.6214 Remote Similarity NPD7640 Approved
0.6211 Remote Similarity NPD6893 Approved
0.62 Remote Similarity NPD5282 Discontinued
0.6196 Remote Similarity NPD7509 Discontinued
0.6186 Remote Similarity NPD5208 Approved
0.618 Remote Similarity NPD6942 Approved
0.618 Remote Similarity NPD7339 Approved
0.617 Remote Similarity NPD6110 Phase 1
0.617 Remote Similarity NPD5362 Discontinued
0.617 Remote Similarity NPD7154 Phase 3
0.6168 Remote Similarity NPD5701 Approved
0.6168 Remote Similarity NPD5697 Approved
0.6163 Remote Similarity NPD6922 Approved
0.6163 Remote Similarity NPD6923 Approved
0.6162 Remote Similarity NPD5693 Phase 1
0.6162 Remote Similarity NPD7637 Suspended
0.6154 Remote Similarity NPD7145 Approved
0.6147 Remote Similarity NPD6371 Approved
0.6139 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6139 Remote Similarity NPD5654 Approved
0.6136 Remote Similarity NPD4732 Discontinued
0.6129 Remote Similarity NPD6898 Phase 1
0.6129 Remote Similarity NPD6902 Approved
0.6126 Remote Similarity NPD4632 Approved
0.6125 Remote Similarity NPD287 Approved
0.6122 Remote Similarity NPD6673 Approved
0.6122 Remote Similarity NPD6904 Approved
0.6122 Remote Similarity NPD6080 Approved
0.6117 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6117 Remote Similarity NPD7638 Approved
0.6111 Remote Similarity NPD6899 Approved
0.6111 Remote Similarity NPD6011 Approved
0.6111 Remote Similarity NPD5128 Approved
0.6111 Remote Similarity NPD4729 Approved
0.6111 Remote Similarity NPD4730 Approved
0.6111 Remote Similarity NPD6686 Approved
0.6111 Remote Similarity NPD7320 Approved
0.6111 Remote Similarity NPD6881 Approved
0.6092 Remote Similarity NPD7144 Approved
0.6092 Remote Similarity NPD7143 Approved
0.6091 Remote Similarity NPD7116 Clinical (unspecified phase)
0.6082 Remote Similarity NPD7750 Discontinued
0.6078 Remote Similarity NPD7614 Phase 1
0.6064 Remote Similarity NPD4800 Clinical (unspecified phase)
0.6061 Remote Similarity NPD7838 Discovery
0.6055 Remote Similarity NPD6013 Approved
0.6055 Remote Similarity NPD4061 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data